Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke - PubMed (original) (raw)
. 2007 Feb 9;1132(1):185-92.
doi: 10.1016/j.brainres.2006.10.098. Epub 2006 Dec 26.
Quan Jiang, Li Zhang, Guangliang Ding, Zheng Gang Zhang, Qingjiang Li, James R Ewing, Mei Lu, Swayamprava Panda, Karyn A Ledbetter, Polly A Whitton, Michael Chopp
Affiliations
- PMID: 17188664
- PMCID: PMC1885791
- DOI: 10.1016/j.brainres.2006.10.098
Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke
Lian Li et al. Brain Res. 2007.
Abstract
To dynamically investigate the long-term response of an ischemic lesion in rat brain to the administration of sildenafil, male Wistar rats subjected to embolic stroke were treated with sildenafil (n=11) or saline (n=10) at a dose of 10 mg/kg administered subcutaneously 24-h after stroke and daily for an additional 6 days. Magnetic resonance images were acquired and functional performance was measured in all animals at 1 day, 2 days and weekly for 6 weeks post-stroke. All rats were sacrificed 6 weeks after stroke and endothelial barrier antigen immunostaining was employed for morphological analysis and quantification of cerebral vessels. Map-ISODATA was computed from T(1), T(2) and T(1sat) maps. ISODATA derived tissue signatures characterize the degree of ischemic injury. Based on the map-ISODATA calculated at 6 weeks, the ischemic lesion for each animal was divided into two specific regions, the ischemic boundary and ischemic core. The temporal profiles of cerebral blood flow (CBF) and tissue signature were retrospectively tracked in these two regions and were compared with histological evaluation and functional outcome. After 1 week of sildenafil treatment, the ischemic lesion exhibited two significantly different regions, with higher CBF level and correspondingly, lower tissue signature value in the boundary region than in the core region. Sildenafil treatment did not significantly reduce the lesion size, but did enhance angiogenesis. Functional performance was significantly increased after sildenafil treatment compared with the control group. Administration of sildenafil to rats with embolic stroke enhances angiogenesis and selectively increases the CBF level in the ischemic boundary, and improves neurological functional recovery compared to saline-treated rats.
Figures
Fig. 1
ISODATA (a) and coregistered EBA-immunostained tissue slice (b) of a rat brain (6-weeks after stroke) showing the two specific regions in the ischemic lesion area and the relationship between angiogenesis area and lesion boundary. The ischemic boundary region (a, transparent ROI) was created by shrinking the rim of ischemic lesion 4 pixels to the ischemic center. The remaining lesion area located inside the boundary region was identified as the ischemic core region (a, solid ROI). The angiogenesis area (b, yellow track) identified by immunohistological evaluation was partially covered by the ischemic lesion area characterized by ISODATA (b, red track). This overlapping area (b, green area) within the lesion was encompassed by the perimeter boundary ROI (comparing a with b).
Fig. 2
Temporal profiles of the ischemic lesion size for the treated and control groups (a) and blood pressure measurements (b). Although the mean values of lesion size were lower in the treated group than in the control group (average from 1 to 6 weeks: 41% vs. 49% of the ipsilateral hemisphere), there was no significant difference between the two groups throughout the experimental period. Sildenafil administered subcutaneously to rats at a dose of 10mg/Kg resulted in a transient but not a significant reduction of blood pressure compared with the pre-treatment level, with the lowest mean blood pressure exhibited 40 minutes after administration and the value gradually returning to the pre-treatment level 120 minutes after administration.
Fig. 3
Immunoreactive cerebral vessels from a treated animal (a, ipsilateral side; b, contralateral side. Bar = 100μm), vessel density (c) and relative CBF (d) in lesion boundary area 6-weeks after stroke. Treatment with sildenafil significantly increased cerebral vessel number in the lesion boundary area compared with the control group (c). Relative CBF in the lesion boundary area was also significantly improved (d) compared with the control group. Significance of difference: * = p < 0.05, comparing treated and control groups in the ischemic boundary region; + = p < 0.05, comparing ischemic boundary region with the homologous area in the contralateral (normal) side of rat brain in treated group and control group, respectively.
Fig. 4
Evolution of CBF (a–b) and tissue signature (c–d) in different regions. Ischemic boundary and ischemic core areas were identified as two significantly different regions by both CBF (a) and tissue signature values (c) for the treated group after the 1-week time point. These two regions, however, for the control group did not differ in both CBF (b) and tissue signature values (d) until 6-weeks. Significance of difference: * = p < 0.05, comparing boundary and core regions at the same time points.
Fig. 5
Neurological functional outcome (a–b) and correlation analysis (c). Treatment with sildenafil significantly improved performance on NSS (a) and on foot-fault test (b) from 2-weeks and 3-weeks after stroke, respectively, until the end of observation compared with control group. Significance of difference: * = p < 0.05, comparing treated and control groups at the same time points. Higher CBF level in the boundary region correlates to lower percentage of foot-faults (c).
Similar articles
- Angiogenesis detected after embolic stroke in rat brain using magnetic resonance T2*WI.
Ding G, Jiang Q, Li L, Zhang L, Zhang ZG, Ledbetter KA, Gollapalli L, Panda S, Li Q, Ewing JR, Chopp M. Ding G, et al. Stroke. 2008 May;39(5):1563-8. doi: 10.1161/STROKEAHA.107.502146. Epub 2008 Mar 20. Stroke. 2008. PMID: 18356548 Free PMC article. - Magnetic resonance imaging investigation of axonal remodeling and angiogenesis after embolic stroke in sildenafil-treated rats.
Ding G, Jiang Q, Li L, Zhang L, Zhang ZG, Ledbetter KA, Panda S, Davarani SP, Athiraman H, Li Q, Ewing JR, Chopp M. Ding G, et al. J Cereb Blood Flow Metab. 2008 Aug;28(8):1440-8. doi: 10.1038/jcbfm.2008.33. Epub 2008 Apr 16. J Cereb Blood Flow Metab. 2008. PMID: 18418368 Free PMC article. - Longitudinal magnetic resonance imaging of sildenafil treatment of embolic stroke in aged rats.
Ding G, Jiang Q, Li L, Zhang L, Zhang Z, Lu M, Li Q, Gu S, Ewing J, Chopp M. Ding G, et al. Stroke. 2011 Dec;42(12):3537-41. doi: 10.1161/STROKEAHA.111.622092. Epub 2011 Sep 8. Stroke. 2011. PMID: 21903952 Free PMC article. - The role of sildenafil in the treatment of stroke.
Bednar MM. Bednar MM. Curr Opin Investig Drugs. 2008 Jul;9(7):754-9. Curr Opin Investig Drugs. 2008. PMID: 18600581 Review. - An old drug for a new application: potential benefits of sildenafil in wound healing.
Farsaie S, Khalili H, Karimzadeh I, Dashti-Khavidaki S. Farsaie S, et al. J Pharm Pharm Sci. 2012;15(4):483-98. doi: 10.18433/j3tc7v. J Pharm Pharm Sci. 2012. PMID: 23106952 Review.
Cited by
- Effects of Sildenafil on Cognitive Function Recovery and Neuronal Cell Death Protection after Transient Global Cerebral Ischemia in Gerbils.
Yu YH, Kim GW, Lee YR, Park DK, Song B, Kim DS. Yu YH, et al. Biomedicines. 2024 Sep 12;12(9):2077. doi: 10.3390/biomedicines12092077. Biomedicines. 2024. PMID: 39335590 Free PMC article. - Synergistic effect of sildenafil combined with controlled hypothermia to alleviate microglial activation after neonatal hypoxia-ischemia in rats.
Julien P, Zinni M, Bonnel N, El Kamouh M, Odorcyk F, Peters L, Gautier EF, Leduc M, Broussard C, Baud O. Julien P, et al. J Neuroinflammation. 2024 Jan 23;21(1):31. doi: 10.1186/s12974-024-03022-w. J Neuroinflammation. 2024. PMID: 38263116 Free PMC article. - A framework of transient hypercapnia to achieve an increased cerebral blood flow induced by nasal breathing during aerobic exercise.
Moris JM, Cardona A, Hinckley B, Mendez A, Blades A, Paidisetty VK, Chang CJ, Curtis R, Allen K, Koh Y. Moris JM, et al. Cereb Circ Cogn Behav. 2023 Sep 13;5:100183. doi: 10.1016/j.cccb.2023.100183. eCollection 2023. Cereb Circ Cogn Behav. 2023. PMID: 37745894 Free PMC article. Review. - Phosphodiesterase-5 (PDE-5) Inhibitors as Therapy for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury.
Kalyani P, Lippa SM, Werner JK, Amyot F, Moore CB, Kenney K, Diaz-Arrastia R. Kalyani P, et al. Neurotherapeutics. 2023 Oct;20(6):1629-1640. doi: 10.1007/s13311-023-01430-z. Epub 2023 Sep 11. Neurotherapeutics. 2023. PMID: 37697134 Free PMC article. Review. - Cellular and molecular mechanisms in vascular repair after traumatic brain injury: a narrative review.
Zhao ZA, Yan L, Wen J, Satyanarayanan SK, Yu F, Lu J, Liu YU, Su H. Zhao ZA, et al. Burns Trauma. 2023 Sep 4;11:tkad033. doi: 10.1093/burnst/tkad033. eCollection 2023. Burns Trauma. 2023. PMID: 37675267 Free PMC article. Review.
References
- Ball GH, Hall DJ. A clustering technique for summarizing multivariate data. Behav Sci. 1967;12:153–155. - PubMed
- Cheitlin MD, Hutter AM, Brindis RG, Ganz P, Kaul S, Russell RO, Zuaman RM. Use of sildenafil (Viagra) in patients with cardiovascular disease. Circulation. 1999;99:168–177. - PubMed
- Chen J, Li Y, Wang L, Zhang ZG, Lu D, Lu M, Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32:1005–1011. - PubMed
- Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, Lu M, Zhu Z, Chopp M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res. 2003a;92:692–699. - PubMed
- Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, Zhang C, Lu M, Katakowski M, Feldkamp CS, Chopp M. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol. 2003b;53:743–751. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS43324/NS/NINDS NIH HHS/United States
- R01 NS48349/NS/NINDS NIH HHS/United States
- P01 NS42345/NS/NINDS NIH HHS/United States
- R01 NS048349/NS/NINDS NIH HHS/United States
- P01 NS023393/NS/NINDS NIH HHS/United States
- R01 NS38292/NS/NINDS NIH HHS/United States
- R01 NS038292/NS/NINDS NIH HHS/United States
- R01 HL064766/HL/NHLBI NIH HHS/United States
- R01 NS043324/NS/NINDS NIH HHS/United States
- HL64766/HL/NHLBI NIH HHS/United States
- P01 NS042345/NS/NINDS NIH HHS/United States
- P01 NS23393/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical